Rubella Virus Antibodies IgG (Serum)
The study is aimed at detecting IgG class antibodies to the rubella virus.
Used for determining past infection or presence of post-vaccination immunity.
Prescribed when planning pregnancy and as part of TORCH screening to assess intrauterine fetal infection risk.
Applied for assessing immune status to rubella virus and planning preventive measures.
Allows the physician to determine the need for vaccination or additional protective measures.
What the test assesses:
– Presence of IgG antibodies to the rubella virus.
– Fact of past infection or formed immunity after vaccination.
– Degree of body protection against reinfection with the virus.
Biomaterial: Venous blood (serum)
– Submit fasting.
– Drinking still water is allowed.
– Avoid intense physical exertion before the test.
Medications:
– Medication intake usually does not affect the result.
– When vaccinating, it is recommended to submit the test before vaccination or no earlier than 4-6 weeks after it.
Recommended for testing:
– When planning pregnancy and managing pregnancy.
– When assessing immune status and the need for vaccination.
– During preventive examinations and assessment of immunity to rubella.
– Positive result (IgG ≥ threshold value): immunity formed, low risk of primary infection.
– Negative result (IgG < threshold value): no immunity present; vaccination or monitoring is recommended, especially when planning pregnancy.
Important — the result should be interpreted considering vaccination history and possible contact with the virus.
